Galmed Pharmaceuticals Ltd. buy Wells Fargo & Company
Start price
06.11.24
/
50%
€6.40
Target price
06.11.25
€81.94
Performance (%)
-
End price
07.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | 4,85 % | -2,75 % | 13,10 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % | 31,34 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % | 44,47 % |
| iShares S&P 500 | 3,32 % | -2,95 % | 24,36 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Company from $78.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
08.08.25
08.08.25
€56.60
08.08.26
08.08.26
-
19.09.24
19.09.24
Stopped prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
26.02.26
26.02.26
€87.99
26.02.27
26.02.27
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
07.11.25
07.11.25
€68.47
07.11.26
07.11.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
21.02.25
21.02.25
€88.72
21.02.26
21.02.26
-
22.02.26
22.02.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
11.12.24
11.12.24
€90.54
11.12.25
11.12.25
-
12.12.25
12.12.25

